Skip to main content

Advertisement

Table 2 Baseline characteristics of DLBCL patients

From: The critical role of RasGRP4 in the growth of diffuse large B cell lymphoma

Patient Gender Age IPI/aa IPI Stage Extranodal Involved Organs LDH Maximum Diameter (cm) SUVmax Value AOD (Rasgrp4 expression)
1 F 72 4 IVB 1 (−) 3 16.1 0.00819
2 M 66 3 IIIA 1 (+) 6 21 0.02483
3 F 76 3 IV 1 (+) 7.8 23 0.03785
4 M 22 2 IVB 3 (+) 14.8 26.9 0.04329
5 F 61 3 IIIA 0 (+) 10.5 17 0.02118
6 M 59 3 IV 2 (+) 7.5 / 0.02108
7 F 70 2 IVA 1 (+) 3 5.9 0.00141
8 F 69 4 IIIB 0 / 4.5 19.3 0.00998
9 M 64 1 IVA 2 (+) 6.6 21.9 0.01752
10 M 37 2 IV 1 / 4 25.3 0.00663
11 F 46 2 IV 2 (−) 19 / 0.0796
12 F 70 2 IIIB 0 (−) 4 / 0.00336
13 F 68 1 IIA 0 (+) 3.3 12.4 0.00286
14 F 54 0 IVA 2 (−) 5 12.3 0.01258
15 F 80 3 IIB 0 (+) 8 / 0.01853
16 M 58 1 IVA 1 (−) 4.5 20.8 0.00869
17 F 59 0 IV 2 (+) 5 10.2 0.01436
18 F 30 1 IIA 0 (−) 6.3 / 0.01246
19 M 74 2 III 0 / 2.8 15 0.0047
20 F 55 2 IV 2 (+) 4 / 0.01799
21 F 63 3 IVA 2 (−) 23 51 0.0499
22 M 43 0 IIA 0 / 3.7 19.1 0.00823
23 F 30 1 IIA 0 (−) 5.2 15.9 0.01324
  1. F female, M male, IPI International Prognostic Index, aaIPI Age-adjusted International Proghostic Index, (+): higher than normal level, (−): normal level, AOD Average optical density